A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010

Completed · Phase 1

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010

Key facts

Study ID

NCT03311373

Run by

Pearl Therapeutics, Inc.

People needed

56

Starts

2017-10-17

Expected to finish

2017-12-15

Last updated by the study team

2020-06-11

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

Where it is running

• Pearl Investigative Site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.